Aridamuriany D. Lubis
Universitas Sumatera Utara

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Factors Associated with Ocular Disorders in Children with Systemic Lupus Erythematosus (SLE) Ivana Garcia Sembiring; Mahrani Lubis; Rosmayanti Syafriani Siregar; Rina Amelia; Rita Evalina; Aridamuriany D. Lubis
Indonesian Journal of Global Health Research Vol. 8 No. 4 (2026): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v8i4.1198

Abstract

Systemic lupus erythematosus (SLE) is a chronic inflammatory disease involving multiple organs and causing systemic damage, characterized by the formation of autoantibodies and immune complexes. Ocular involvement is estimated to occur in approximately one-third of individuals with SLE and may affect various ocular structures. Ocular manifestations associated with SLE are highly variable and may lead to delayed diagnosis, potentially resulting in poor outcomes and vision-threatening complications. To analyze risk factors associated with ocular disorders in children with systemic lupus erythematosus (SLE). This was an analytic cross-sectional study conducted at the Allergy-Immunology outpatient clinic and pediatric inpatient ward of Adam Malik General Hospital starting in April 2025. The sampling technique used was consecutive sampling. A total of 41 patients with SLE were analyzed. The duration of treatment was found to be a risk factor associated with ocular disorders in children with SLE (p=0.005). The prevalence of ocular disorders among children with SLE was 29.3%. The most common ocular disorder observed in children with SLE undergoing treatment was ocular hypertension, found in 9 patients (22%). Based on ordinal regression analysis, each additional year of treatment duration increased the likelihood of worsening therapeutic outcomes by 1.76 times (p<0.05). Treatment duration is a significant risk factor for ocular disorders in children with systemic lupus erythematosus, with ocular hypertension being the most common type of ocular disorder. Longer treatment duration increases the likelihood of worsening therapeutic outcomes.
Description of Patient Demographic Characteristics and Mortality of Pediatric Sepsis Patients Kartini Marpaung; Aridamuriany D. Lubis; Winra Pratita
Jurnal Keperawatan Priority Vol. 9 No. 2 (2026)
Publisher : Universitas Prima Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34012/jukep.v9i2.8078

Abstract

Sepsis in children is a health problem associated with high morbidity and mortality. Lactate levels are a biomarker used to assess perfusion disorders and risk stratification in sepsis patients. However, evidence regarding the relationship between lactate levels and mortality in pediatric sepsis patients in Indonesia is still limited. This study aims to determine the demographic, clinical, and laboratory characteristics, mortality, and the relationship between lactate levels and mortality in pediatric patients with sepsis in the Pediatric Intensive Care Unit (PICU) of Haji Adam Malik General Hospital, Medan. The study used a descriptive quantitative design in the PICU. The population included pediatric patients with sepsis who were admitted from January 2023 to February 2024. The sample was selected using sequential sampling based on inclusion and exclusion criteria, with 101 patients. Data were obtained from medical records and analyzed descriptively and the relationship between lactate levels and mortality. Of the 157 patients, 101 met the study criteria. The majority were female (57.4%) and had normal nutritional status (39.6%). Respiratory distress was the most common indication for PICU admission (50.5%). The median length of stay was 5 days (1–79 days). A total of 72 patients (71.3%) died. The mean lactate level was 27.15 ± 26.12 mg/dL with a median of 20.2 mg/dL (4–166.5 mg/dL). The median lactate level in deceased patients was higher than in survivors (25.1 vs. 11.9 mg/dL; p<0.001). A cut-off of 18.1 mg/dL had a sensitivity of 68.1%, a specificity of 86.2%, a positive predictive value of 92.6%, and a negative predictive value of 53.1%. Mortality was high. Higher lactate levels can be considered a biomarker to help stratify mortality risk.